The facility is housed with three Clinical Pharmacology Units with an 80 bed facility to cater to both early and late phase development as well as life cycle chain management.
SRC executive director and president Krathish Bopanna said that the expansion will give SRC an opportunity to unite the world of pharmaceutical research across the globe and enable them to complete the loop in the drug development cycle by providing easy access to state-of-the-art facilities for early stage research in India.
“We look forward to added expansion that will contribute towards further evolution of the Indian contract research and development industry. As a company, we also envisage enormous potential in biometric space where we hope to delve further through inorganic growth strategies,” Bopanna said.